The Ocular Drug Delivery Devices Market was valued at USD 13.03 billion in 2023 and is expected to reach USD 27.13 billion by 2032, growing at a CAGR of 8.54% from 2024 to 2032. This growth is fueled by the increasing prevalence of ocular diseases, such as age-related macular degeneration (AMD), diabetic retinopathy, and glaucoma, which require long-term treatment and effective drug delivery sys..